Basophilic leukemia presenting as gastroduodenal ulceration: effect of H-2-receptor blockade
- PMID: 717356
- DOI: 10.1007/BF01072474
Basophilic leukemia presenting as gastroduodenal ulceration: effect of H-2-receptor blockade
Abstract
A patient with multiple gastroduodenal ulcers and gastric hypersecretion due to histamine excess associated with basophilic leukemia is described. Treatment with the histamine H-2-receptor blocker, cimetidine, was able to abolish the gastric hypersecretion and gastrointestinal blood loss. A literature review produced four other cases of multiple gastroduodenal ulceration with this disease, suggesting that it is more common than previously recognized. The availability of a potent H-2-receptor antagonist offers effective and specifically tailored therapy to counteract the gastrointestinal effects of hyperhistaminemia in basophilic leukemia and other "histamine excess" diseases.
Similar articles
-
[Histamine as the principal pathogenetic factor in gastroduodenal ulcer. Research priorities].Minerva Med. 1980 Sep 1;71(31):2193-7. Minerva Med. 1980. PMID: 6158718 Italian.
-
Effect of cimetidine treatment on parietal and chief cell sensitivity to histamine and on catabolism of histamine in duodenal ulcer patients.Scand J Gastroenterol. 1980;15(6):749-54. doi: 10.3109/00365528009181525. Scand J Gastroenterol. 1980. PMID: 6782649
-
Basophilic leukemia.South Med J. 1980 Jul;73(7):934-6. doi: 10.1097/00007611-198007000-00031. South Med J. 1980. PMID: 6930107
-
Cimetidine for stress-ulcer prophylaxis.Crit Care Med. 1984 Jul;12(7):571-5. doi: 10.1097/00003246-198407000-00005. Crit Care Med. 1984. PMID: 6375965 Review.
-
[New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)].Farmakol Toksikol. 1978 Sep-Oct;41(5):624-32. Farmakol Toksikol. 1978. PMID: 81139 Review. Russian. No abstract available.
Cited by
-
Medical staff conference: cimetidine.West J Med. 1979 Nov;131(5):417-25. West J Med. 1979. PMID: 532144 Free PMC article. No abstract available.